Today a lot of pharmaceutical companies are ready to cooperate with anti-doping agencies in their fight against usage of forbidden products in sports. It sounds strange but this is the reality. In fact, if you review the fate of EPO, you can understand why pharmaceutical companies agree to support efforts of anti-doping agencies. EPO is really an efficient remedy for treatment of anemia. A lot of individuals with anemia that have applied EPO have been treated. But what do you think while hearing about this medicine? Almost any individual associates this remedy just with doping in sports. This medication has been abused by Lance Armstrong that has cheated the whole world. Thus, EPO is associated just with cheating, dishonor, etc. Looking at this case, pharmaceutical companies try to “defend” their medicines from the similar fate. That’s why they cooperate with anti-doping agencies.
Although certain drug manufacturers began to collaborate with anti-doping officers long ago, sometimes there were certain problems between them. Anti-doping officers criticized several drug manufacturers for their links to doping.
Today relations between anti-doping officials and drug manufacturers are closer. Drug manufacturers share detailed information about new medications with anti-doping officers. It is precious information for development of detection tests for these drugs. While anti-doping officers learn how medicines are manufactured, how they pass into body, how they work in the body, they can introduce more efficacious tests for these preparations.
For example, the drug manufacturer Roche that elaborated the medicine CERA helped anti-doping officers to introduce a detection test for it. Later other companies followed the example of Roche. The pharmaceutical company GlaxoSmithKline went so far, as it sponsored an anti-doping lab during London Olympics.
While relations between anti-doping officers and huge drug manufacturers become closer, smaller pharmaceutical companies started to collaborate with anti-doping officials as well. While earlier drug manufacturers haven’t desired to discuss about their relations with anti-doping officers publicly, today they don’t fear to announce about this condition.
Комментариев нет:
Отправить комментарий